Moxifloxacin Ophthalmic Solution, USP 0.5% w/v, 3 mL bottle, Sterile, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, Made in India, NDC 65862-840-03
Published February 23, 2022 · Recall initiated: January 14, 2022
Summary
FDA records drug Class II recall D-0560-2022, published February 23, 2022 and initiated January 14, 2022. Recalling firm: Aurobindo Pharma USA Inc.; Status: Terminated; Reported quantity: 115776 bottles; Lot: Lot#: CMF210001, CMF210003, CMF210004, Exp 6/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications
What to do
Voluntary: Firm initiated · Letter
Get an email if MOXIFLOXACIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- MOXIFLOXACIN
- Manufacturer
- Aurobindo Pharma USA Inc.
- Distributor
- USA Nationwide
- UPC
- 0365862840035
- Lot
- Lot#: CMF210001, CMF210003, CMF210004, Exp 6/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDANaturesPlus Advanced Therapeutics Glucosamine Chondroitin MSM Ultra Rx- Joint Cream, 4 oz tubes, ManufacturedFebruary 23, 2022
- FDAMAC DADDY RED Capsules, packaged in 10-count blisters per carton, ASIN B07TLDZLY2, UPC 742137 605191.February 23, 2022
- FDADiazepam Oral Solution (Concentrate), 25 mg per 5 mL (5 mg/mL), 30 mL BOTTLE and DROPPER, Rx Only, DistributedFebruary 23, 2022
- FDAMAC DADDY PURPLE Capsules, packaged in 10-count blisters per carton, ASIN B08Z63Z4QK, UPC 742137 605764.February 23, 2022
- FDAMoxifloxacin Ophthalmic Solution USP, 0.5%, Sterile, 3mL Bottle, Rx Only, For Topical Ophthalmic Use Only,January 22, 2020
- FDAMoxifloxacin Ophthalmic Solution USP, 0.5%, 5 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals Inc.August 8, 2018
Questions about this recall
Was Moxifloxacin Ophthalmic Solution, USP 0.5% w/v, 3 mL bottle, Sterile, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, Made in India, NDC 65862-840-03 recalled?
Yes. FDA published recall D-0560-2022 on February 23, 2022. Reported hazard: Failed Impurities/Degradation Specifications
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: MOXIFLOXACIN. UPC: 0365862840035.